Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Melatonin

Brand: 
NICE TA: 
Indication: Children and adults with learning disabilities (LD) and neurodevelopmental disorders
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No

Background

It was decided at the June meeting of the LMMG that melatonin for the management of insomnia in children and adults with neurodevelopmental disorders would be RAG rated Amber 0.

Continued prescribing of melatonin should only occur in patients whose initial response to and progress on this medication is considered satisfactory.

Clinicians prescribing melatonin should refer to the LMMG prescribing information sheet on melatonin for further information, including how and when to introduce treatment holidays.

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

Melatonin Position Statement (Version 1.2) (615.1 KiB)

Melatonin Prescribing Information Sheet (Version 1.0) (664.4 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Local decision to be confirmed

Amber0

Amber0

Amber0